Skip to main content

Table 1 Clinical description of the sample studied (n = 137)

From: Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome

Characteristic

N

%

Mean (SD)

Sex

   

   Female

134

97.8

 

   Male

3

2.2

 

Age at breast cancer (years)*

  

42.3 (8.3) range: 24-73

Inclusion criteria

   

   ASCO

113

82.5

 

   Probability of mutation (Myriad) ≥ 30%

62

45.3

 

   Probability of mutation (PENN II model) ≥ 30%

28

20.4

 

   Bilateral breast cancer

34

24.8

 

Cancer history in the proband (n = 136)**

   

One primary tumor

   

Breast cancer

85

62.5

 

   Ovarian cancer

4

2.9

 

   Other#

5

3.7

 

Multiple primaries:

   

   ≥ 2 Breast

31

22.8

 

   ≥ 2 ovarian

0

0

 

   1breast and 1 ovarian

2

1.5

 

   ≥ 2 Breast and 1 ovarian

3

2.2

 

   At least one breast + other

5

3.7

 

   At least one ovarian + other

1

0.7

 

Criteria for multiple hereditary cancer syndromes

   

   HBOC + Li-FraumeniLike (Eeles criteria)

23

16.8

 

   HBOC + Li-Fraumeni Like (Birch criteria)

2

1.4

 

   HBOC + Hereditary Breast and Colorectal Cancer

14

10.2

 

   HBOC + Hereditary Non-Polyposis Colorectal Cancer

3

2.2

 

Cancer family history (1 st and 2 nd degree relatives)

   

   Number of breast cancer cases

  

3.3 (1.52)

   Number of ovarian cancer cases

  

1.3 (0.61)

   Age at first breast cancer

  

44.2 (6.8)

  1. *In women with multiple breast cancers, age at the diagnosis of the first primary was considered.
  2. **One patient was cancer unaffected. In the sample of 136 cancer affected probands, there were a total of 184 tumors, including synchronous and metachronous cases.
  3. #(colorectal, melanoma, gastric, uterine cervix, esophagus, endometrium)